Epilepsies, Partial Clinical Trial
Official title:
MRI in Autosomal Dominant Partial Epilepsy With Auditory Features
This study will examine the possible structural and functional abnormalities in patients with
an inherited form of epilepsy. It will use magnetic resonance imaging (MRI). Uncontrolled
epilepsy is a serious neurological problem with major harmful medical, social, and
psychological effects, as well as greater mortality compared with the general population. The
cost per year in the United States is at least $12.5 billion. There have been advances in
diagnosing the disease, but the cause cannot be determined in many cases. Recently, several
seizure syndromes found in families have been described. One syndrome of particular interest
involves the lateral temporal lobe of the brain and often includes auditory features.
Patients with that kind of syndrome may hear monotonous unformed sounds, but sometimes they
may hear complex sounds, such as a song.
Patients are eligible for this study if they have a specific form of familial epilepsy that
is being studied at Columbia University in New York. Family members without seizures are
eligible as well. All the patients in the study will be evaluated at Columbia before
participating. Healthy volunteers aged 18 to 55 also may be eligible for this study.
Participants will undergo a medical history and physical examination. During the study, they
may have three or four sessions of MRI. During the MRI, patients will lie still on a table
that can slide in and out of a metal cylinder surrounded by a strong magnetic field. Scanning
time varies from 20 minutes to 3 hours, with most scans lasting between 45 and 90 minutes.
Patients may be asked to lie still for up to 60 minutes at a time. As the scanner takes
pictures, there will be loud knocking noises, and the patients will wear earplugs to muffle
the sound. Patients will be able to communicate with the MRI staff at all times during the
scan and may ask to be moved out of the machine at any time. Some scans may be done in a 3
Tesla scanner. It is the latest advance in MRI, with a stronger magnetic field than in the
more common 1.5 Tesla scanner. Functional MRI (fMRI) is done while patients are performing
tasks, such as moving a limb or speaking. Patients will have an opportunity to practice such
tasks before entering the scanner. The fMRI will take about 1 hour.
Objectives: to study potential structural and functional abnormalities in patients with an
inherited form of epilepsy.
Study Population: Patients with autosomal dominant partial epilepsy with auditory features, a
newly described syndrome, asymptomatic family members who are gene carriers, and unaffected
family members, and normal volunteers.
Design: magnetic resonance imaging, electroencephalography, and magnetoencephalography.
Outcome measures: detection of structural lesions; regional activation patterns on fMRI.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00524030 -
Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
|
Phase 3 | |
Completed |
NCT00143143 -
Pregabalin Open-Label Extension Trial in Patients With Partial Seizures
|
Phase 3 | |
Completed |
NCT00771927 -
Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures
|
N/A | |
Completed |
NCT00236873 -
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
|
Phase 2 | |
Completed |
NCT01745952 -
Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)
|
N/A | |
Completed |
NCT00772603 -
Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures
|
Phase 3 | |
Completed |
NCT00280696 -
A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures
|
Phase 3 | |
Completed |
NCT00643136 -
A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures
|
Phase 3 | |
Completed |
NCT00230698 -
A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure
|
Phase 3 | |
Enrolling by invitation |
NCT04309812 -
Transcranial Direct Current to Treat Epilepsy at Home
|
Early Phase 1 | |
Completed |
NCT00620555 -
A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures
|
Phase 3 | |
Withdrawn |
NCT00422110 -
A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures
|
Phase 2/Phase 3 | |
Completed |
NCT00448916 -
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
|
Phase 3 | |
Completed |
NCT00210522 -
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
|
Phase 2 | |
Completed |
NCT00236886 -
Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients
|
Phase 3 | |
Completed |
NCT00236860 -
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures
|
Phase 2 | |
Active, not recruiting |
NCT03689114 -
Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)
|
Phase 4 | |
Completed |
NCT01098162 -
Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug
|
N/A | |
Completed |
NCT05273398 -
Effects of Diazepam on RNS Detections
|
Phase 4 | |
Completed |
NCT00918047 -
Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients
|
Phase 1 |